Wu X - Search Results

1

RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.

Yu X, Zhao P, Luo Q, Wu X, Wang Y, Nan Y, Liu S, Gao W, Li B, Liu Z, Cui Z. Yu X, et al. Among authors: wu x. Oncogene. 2024 Feb;43(6):420-433. doi: 10.1038/s41388-023-02910-4. Epub 2023 Dec 14. Oncogene. 2024. PMID: 38092960

2

MicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinoma.

Jing C, Ma G, Li X, Wu X, Huang F, Liu K, Liu Z. Jing C, et al. Among authors: wu x. Am J Cancer Res. 2016 Jul 1;6(7):1549-62. eCollection 2016. Am J Cancer Res. 2016. PMID: 27508097 Free PMC article.

3

MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.

Wu X, Li L, Li Y, Liu Z. Wu X, et al. Am J Cancer Res. 2016 Jul 1;6(7):1563-71. eCollection 2016. Am J Cancer Res. 2016. PMID: 27508098 Free PMC article.

4

S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.

Tian T, Li X, Hua Z, Ma J, Wu X, Liu Z, Chen H, Cui Z. Tian T, et al. Among authors: wu x. Oncotarget. 2017 Apr 11;8(15):24964-24977. doi: 10.18632/oncotarget.15329. Oncotarget. 2017. PMID: 28212564 Free PMC article.

5

Integrin β1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma.

Xu Z, Zou L, Ma G, Wu X, Huang F, Feng T, Li S, Lin Q, He X, Liu Z, Cao X. Xu Z, et al. Among authors: wu x. Am J Cancer Res. 2017 Mar 1;7(3):531-542. eCollection 2017. Am J Cancer Res. 2017. PMID: 28401009 Free PMC article.

6

The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation.

Li Y, Wu X, Li L, Liu Y, Xu C, Su D, Liu Z. Li Y, et al. Among authors: wu x. Cancer Lett. 2017 Sep 28;404:44-52. doi: 10.1016/j.canlet.2017.07.004. Epub 2017 Jul 15. Cancer Lett. 2017. PMID: 28716524

7

Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.

Shu T, Li Y, Wu X, Li B, Liu Z. Shu T, et al. Among authors: wu x. Cancer Lett. 2017 Dec 28;411:65-73. doi: 10.1016/j.canlet.2017.09.048. Epub 2017 Oct 6. Cancer Lett. 2017. PMID: 28989055

8

ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2.

Luo Q, Wu X, Zhang Y, Shu T, Ding F, Chen H, Zhao P, Chang W, Zhu X, Liu Z. Luo Q, et al. Among authors: wu x. Cancer Lett. 2018 Jul 28;427:9-17. doi: 10.1016/j.canlet.2018.04.013. Epub 2018 Apr 13. Cancer Lett. 2018. PMID: 29660381

9

Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer.

Zhang Y, Huang F, Luo Q, Wu X, Liu Z, Chen H, Huang Y. Zhang Y, et al. Among authors: wu x. Onco Targets Ther. 2018 Dec 5;11:8751-8759. doi: 10.2147/OTT.S171053. eCollection 2018. Onco Targets Ther. 2018. PMID: 30584333 Free PMC article.

10

MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer.

Wu X, Luo Q, Zhao P, Chang W, Wang Y, Shu T, Ding F, Li B, Liu Z. Wu X, et al. Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2961-2966. doi: 10.1073/pnas.1814742116. Epub 2019 Feb 4. Proc Natl Acad Sci U S A. 2019. PMID: 30718431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,197 results

Search Page

Filters